VIDEO: ‘Focus on preservation of renal function’ when managing anemia in patients with CKD

Editor’s note: This is a previously posted video, and the below is an automatically generated transcript to be used for informational purposes. Please notify editor@healio.com if there are concerns regarding accuracy of the transcription.

We talk about it a lot, but it's a small part of the picture of making patients better. The big core is focus on preservation of renal function in CKD, and I mentioned previously, SGLT2 inhibitors slow down progressive renal failure and actually raise hemoglobin. They seem to mobilize iron, and so using iron in that population can be effective also for keeping hemoglobins higher, making people feel better, and ultimately living longer lives. And that's what it's all about.